239 related articles for article (PubMed ID: 8944072)
1. Allelotypic and cytogenetic characterization of chemically induced mouse mammary tumors: high frequency of chromosome 4 loss of heterozygosity at advanced stages of progression.
Aldaz CM; Liao QY; Paladugu A; Rehm S; Wang H
Mol Carcinog; 1996 Nov; 17(3):126-33. PubMed ID: 8944072
[TBL] [Abstract][Full Text] [Related]
2. Loss of heterozygosity occurs via mitotic recombination in Trp53+/- mice and associates with mammary tumor susceptibility of the BALB/c strain.
Blackburn AC; McLary SC; Naeem R; Luszcz J; Stockton DW; Donehower LA; Mohammed M; Mailhes JB; Soferr T; Naber SP; Otis CN; Jerry DJ
Cancer Res; 2004 Aug; 64(15):5140-7. PubMed ID: 15289317
[TBL] [Abstract][Full Text] [Related]
3. Allelic imbalance in mammary carcinomas induced by either 7,12-dimethylbenz[a]anthracene or ionizing radiation in rats carrying genes conferring differential susceptibilities to mammary carcinogenesis.
Haag JD; Hsu LC; Newton MA; Gould MN
Mol Carcinog; 1996 Nov; 17(3):134-43. PubMed ID: 8944073
[TBL] [Abstract][Full Text] [Related]
4. Nonrandom abnormalities involving chromosome 1 and Harvey-ras-1 alleles in rat mammary tumor progression.
Aldaz CM; Chen A; Gollahon LS; Russo J; Zappler K
Cancer Res; 1992 Sep; 52(17):4791-8. PubMed ID: 1511443
[TBL] [Abstract][Full Text] [Related]
5. Microsatellite instability and loss of heterozygosity on chromosome 10 in rat mammary tumors induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
Toyota M; Ushijima T; Weisburger JH; Hosoya Y; Canzian F; Rivenson A; Imai K; Sugimura T; Nagao M
Mol Carcinog; 1996 Mar; 15(3):176-82. PubMed ID: 8597530
[TBL] [Abstract][Full Text] [Related]
6. Natural and synthetic progestins accelerate 7,12-dimethylbenz[a]anthracene-initiated mammary tumors and increase angiogenesis in Sprague-Dawley rats.
Benakanakere I; Besch-Williford C; Schnell J; Brandt S; Ellersieck MR; Molinolo A; Hyder SM
Clin Cancer Res; 2006 Jul; 12(13):4062-71. PubMed ID: 16818706
[TBL] [Abstract][Full Text] [Related]
7. Loss of heterozygosity analysis in primary mammary tumors and lung metastases of MMTV-MTAg and MMTV-neu transgenic mice.
Ritland SR; Rowse GJ; Chang Y; Gendler SJ
Cancer Res; 1997 Aug; 57(16):3520-5. PubMed ID: 9270023
[TBL] [Abstract][Full Text] [Related]
8. Allelotype analysis of chemically induced squamous cell carcinomas in F(1) hybrids of two inbred mouse strains with different susceptibility to tumor progression.
Stern MC; Benavides F; Klingelberger EA; Conti CJ
Carcinogenesis; 2000 Jul; 21(7):1297-301. PubMed ID: 10874006
[TBL] [Abstract][Full Text] [Related]
9. Medroxyprogesterone acetate accelerates the development and increases the incidence of mouse mammary tumors induced by dimethylbenzanthracene.
Aldaz CM; Liao QY; LaBate M; Johnston DA
Carcinogenesis; 1996 Sep; 17(9):2069-72. PubMed ID: 8824536
[TBL] [Abstract][Full Text] [Related]
10. Loss of heterozygosity on chromosomes 1, 11, 12, and 14 in hybrid mouse lung adenocarcinomas.
Herzog CR; Chen B; Wang Y; Schut HA; You M
Mol Carcinog; 1996 Jun; 16(2):83-90. PubMed ID: 8645430
[TBL] [Abstract][Full Text] [Related]
11. Activation of H-ras oncogenes in preneoplastic mouse mammary tissues.
Kumar R; Medina D; Sukumar S
Oncogene; 1990 Aug; 5(8):1271-7. PubMed ID: 2118247
[TBL] [Abstract][Full Text] [Related]
12. Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability.
McCormack SJ; Weaver Z; Deming S; Natarajan G; Torri J; Johnson MD; Liyanage M; Ried T; Dickson RB
Oncogene; 1998 May; 16(21):2755-66. PubMed ID: 9652742
[TBL] [Abstract][Full Text] [Related]
13. A mammary cancer suppressor gene and its site of action in the rat.
Isaacs JT
Cancer Res; 1991 Mar; 51(6):1591-5. PubMed ID: 1900214
[TBL] [Abstract][Full Text] [Related]
14. A mammary-specific model demonstrates the role of the p53 tumor suppressor gene in tumor development.
Jerry DJ; Kittrell FS; Kuperwasser C; Laucirica R; Dickinson ES; Bonilla PJ; Butel JS; Medina D
Oncogene; 2000 Feb; 19(8):1052-8. PubMed ID: 10713689
[TBL] [Abstract][Full Text] [Related]
15. Induction of mammary tumors in virgin female BALB/c mice by single low doses of 7,12-dimethylbenz[a]anthracene.
Ethier SP; Ullrich RL
J Natl Cancer Inst; 1982 Nov; 69(5):1199-203. PubMed ID: 6813553
[TBL] [Abstract][Full Text] [Related]
16. Decreased tumor formation in 7,12-dimethylbenzanthracene-treated stromelysin-1 transgenic mice is associated with alterations in mammary epithelial cell apoptosis.
Witty JP; Lempka T; Coffey RJ; Matrisian LM
Cancer Res; 1995 Apr; 55(7):1401-6. PubMed ID: 7882342
[TBL] [Abstract][Full Text] [Related]
17. Carcinogen-specific targeting of chromosome 12 for loss of heterozygosity in mouse lung adenocarcinomas: implications for chromosome instability and tumor progression.
Herzog CR; Bodon N; Pittman B; Maronpot RR; Massey TE; Anderson MW; You M; Devereux TR
Oncogene; 2004 Apr; 23(17):3033-9. PubMed ID: 14755239
[TBL] [Abstract][Full Text] [Related]
18. Interactions between progestins and heregulin (HRG) signaling pathways: HRG acts as mediator of progestins proliferative effects in mouse mammary adenocarcinomas.
Balañá ME; Lupu R; Labriola L; Charreau EH; Elizalde PV
Oncogene; 1999 Nov; 18(46):6370-9. PubMed ID: 10597237
[TBL] [Abstract][Full Text] [Related]
19. Reduced circulating insulin-like growth factor I levels delay the onset of chemically and genetically induced mammary tumors.
Wu Y; Cui K; Miyoshi K; Hennighausen L; Green JE; Setser J; LeRoith D; Yakar S
Cancer Res; 2003 Aug; 63(15):4384-8. PubMed ID: 12907608
[TBL] [Abstract][Full Text] [Related]
20. Cytogenetic findings, Trp53 mutations, and hormone responsiveness in a medroxyprogesterone acetate induced murine breast cancer model.
Fabris VT; Benavides F; Conti C; Merani S; Lanari C
Cancer Genet Cytogenet; 2005 Sep; 161(2):130-9. PubMed ID: 16102583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
